Anti-neoplastic characteristics and potential targets of calycosin against bisphenol A-related osteosarcoma:...

Area of Science:

• Pharmacology and Toxicology
• Computational Biology
• Oncology

Background:

• Bisphenol A (BPA) is an environmental pollutant linked to health risks, including osteosarcoma (OS).
• Current pharmacotherapy options for OS are limited, necessitating the exploration of novel therapeutic agents.
• Calycosin has demonstrated potential anti-OS activities in preliminary studies.

Purpose of the Study:

• To investigate the therapeutic targets and molecular mechanisms of calycosin in treating BPA-related OS.
• To utilize network pharmacology and molecular docking to elucidate calycosin's action against BPA-induced OS.

Main Methods:

• Network pharmacology analysis to identify core targets, biological functions, and molecular pathways.
• Molecular docking to assess the binding potential of calycosin to identified targets.
• Integration of bioinformatics and structural biology data.

Main Results:

• Bioinformatics analysis mapped core targets and pathways for calycosin in treating BPA-related OS.
• Molecular docking confirmed the binding ability of calycosin to key therapeutic targets.
• Integrated network maps revealed detailed biological functions and optimal pathways involved.

Conclusions:

• Network pharmacology and molecular docking identified core biotargets, pharmacological functions, and pathways for calycosin against BPA-related OS.
• The identified targets may hold potential for the clinical application of calycosin in treating BPA-induced osteosarcoma.